Author: Yamashita Takenari Akamatsu Megumi Kwak Shin
Publisher: MDPI
E-ISSN: 2073-4425|8|2|60-60
ISSN: 2073-4425
Source: Genes, Vol.8, Iss.2, 2017-02, pp. : 60-60
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Transactive response DNA-binding protein (TDP-43) pathology, and failure of A-to-I conversion (RNA editing) at the glutamine/arginine (Q/R) site of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor subunit GluA2, are etiology-linked molecular abnormalities that concomitantly occur in the motor neurons of most patients with amyotrophic lateral sclerosis (ALS). Adenosine deaminase acting on RNA 2 (ADAR2) specifically catalyzes GluA2 Q/R site-RNA editing. Furthermore, conditional ADAR2 knockout mice (AR2) exhibit a progressive ALS phenotype with TDP-43 pathology in the motor neurons, which is the most reliable pathological marker of ALS. Therefore, the evidence indicates that ADAR2 downregulation is a causative factor in ALS, and AR2 mice exhibit causative molecular changes that occur in ALS. We discuss the contributors to ADAR2 downregulation and TDP-43 pathology in AR2 mouse motor neurons. We describe mechanisms of exaggerated Ca2+ influx amelioration via AMPA receptors, which is neuroprotective in ADAR2-deficient motor neurons with normalization of TDP-43 pathology in AR2 mice. Development of drugs to treat diseases requires appropriate animal models and a sensitive method of evaluating efficacy. Therefore, normalization of disrupted intracellular environments resulting from ADAR2 downregulation may be a therapeutic target for ALS. We discuss the development of targeted therapy for ALS using the AR2 mouse model.
Related content
By Subramanian Vasanta Crabtree Benedict Acharya K. Ravi
Human Molecular Genetics, Vol. 17, Iss. 1, 2008-01 ,pp. :
By Teuling Eva van Dis Vera Wulf Phebe S. Haasdijk Elize D. Akhmanova Anna Hoogenraad Casper C. Jaarsma Dick
Human Molecular Genetics, Vol. 17, Iss. 18, 2008-09 ,pp. :
By Prause J. Goswami A. Katona I. Roos A. Schnizler M. Bushuven E. Dreier A. Buchkremer S. Johann S. Beyer C. Deschauer M. Troost D. Weis J.
Human Molecular Genetics, Vol. 22, Iss. 8, 2013-04 ,pp. :
By Martorana Francesca Brambilla Liliana Valori Chiara F. Bergamaschi Chiara Roncoroni Chiara Aronica Eleonora Volterra Andrea Bezzi Paola Rossi Daniela
Human Molecular Genetics, Vol. 21, Iss. 4, 2012-02 ,pp. :